Press release
RNA Sequencing Market Forecast: Promising Growth Potential from 2021 to 2031
RNA Sequencing Market, RNA Sequencing Market size, RNA Sequencing Market Share
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐จ๐ซ ๐ ๐ฌ๐๐ฆ๐ฉ๐ฅ๐ ๐จ๐ ๐ญ๐ก๐ข๐ฌ ๐ซ๐๐ฌ๐๐๐ซ๐๐ก ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐๐ญ (๐๐ฌ๐ ๐๐จ๐ซ๐ฉ๐จ๐ซ๐๐ญ๐ ๐๐๐ข๐ฅ ๐๐ ๐๐จ๐ซ ๐๐ฎ๐ข๐๐ค ๐๐๐ฌ๐ฉ๐จ๐ง๐ฌ๐) - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=81921&utm_source=OpenPR_Ajay&utm_medium=OpenPR
However, the market faces challenges such as the requirement for skilled professionals, high initial capital investment, and storage issues associated with sequencing data. The efficiency of RNA-based mappings also poses a challenge for short-lived transcripts.
North America currently dominates the RNA sequencing market, with a major share attributed to the region. The increasing research activities on cancer and inherited rare diseases, government support through funds for genomics research, and the presence of key players like Thermo Fisher, Illumina, and Agilent Technologies contribute to the market's growth in North America.
๐๐ฎ๐ฒ ๐ญ๐ก๐ข๐ฌ ๐๐ซ๐๐ฆ๐ข๐ฎ๐ฆ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐๐ฉ๐จ๐ซ๐ญ | ๐๐ฆ๐ฆ๐๐๐ข๐๐ญ๐ ๐๐๐ฅ๐ข๐ฏ๐๐ซ๐ฒ ๐๐ฏ๐๐ข๐ฅ๐๐๐ฅ๐ ๐๐ญ - https://www.transparencymarketresearch.com/checkout.php?rep_id=81921<ype=S&utm_source=OpenPR_Ajay&utm_medium=OpenPR
The global RNA sequencing market is highly fragmented, with various key players operating in different regions. Some of the major players in the market include Thermo Fisher Scientific, Agilent Technologies Inc., Illumina, Tecan Genomics Inc., F. Hoffmann-La Roche Ltd, PerkinElmer Inc., GE Healthcare, Bio-Rad Laboratories Inc., Sigma Aldrich, Eurofins Scientific, and Oxford Nanopore Technologies.
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐จ๐ซ ๐๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐๐ญ๐ข๐จ๐ง ๐จ๐ ๐ญ๐ก๐ข๐ฌ ๐ซ๐๐ฌ๐๐๐ซ๐๐ก ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐๐ญ -ย https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=81921&utm_source=OpenPR_Ajay&utm_medium=OpenPR
The market can be segmented based on type, technology, application, end-user, and region. Types of RNA sequencing products include data analysis and management, sequencing platforms, and consumables & services. Technologies used in RNA sequencing include sequencing by synthesis, single molecule real-time sequencing, nanopore sequencing, and Ion semiconductor sequencing. Applications of RNA sequencing include expression profiling analysis, de novo transcriptome assembly, small RNA sequencing, transcriptome analysis, and variant calling. End-users of RNA sequencing include hospitals and diagnostic centers, academic and research institutes, pharmaceutical & biotechnology companies, and others.
๐๐จ๐ซ๐ ๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ ๐๐ฒ ๐๐ซ๐๐ง๐ฌ๐ฉ๐๐ซ๐๐ง๐๐ฒ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก -
Bioinformatics Market
https://www.globenewswire.com/en/news-release/2023/04/05/2641683/0/en/Bioinformatics-Market-Revenue-to-Cross-USD-44-9-Bn-by-2028-with-CAGR-of-5-9-TMR-Study.html
Tracheostomy Devices Market
https://www.globenewswire.com/en/news-release/2023/04/04/2641254/0/en/Tracheostomy-Devices-Market-Size-to-Cross-USD-291-3-Mn-Revenue-by-2031-Due-to-the-Rise-in-Demand-for-Homecare-Services-TMR-Study.html
About Us Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.
Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.
Contact Us
Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release RNA Sequencing Market Forecast: Promising Growth Potential from 2021 to 2031 here
News-ID: 3157313 • Views: โฆ
More Releases from Transparency Market Research
Handheld Marijuana Vaporizer Market Key Drivers, Market Research, and Insights f โฆ
The global handheld marijuana vaporizer market has witnessed remarkable growth in recent years, attributed to the increasing acceptance of medicinal marijuana and the demand for convenient and discreet consumption methods. Valued at US$ 5 billion in 2021, the market is projected to surge at a CAGR of 13.4% to reach US$ 15.9 billion by 2031. This article delves into the factors driving this growth, the evolving market landscape, and theโฆ
Disinfectant Wipes Market Forecast 2020-2030 - Market Size, Drivers, Trends, And โฆ
The COVID-19 pandemic has precipitated a remarkable surge in the demand for disinfectant products, with a notable emphasis on disinfectant wipes as an essential tool in maintaining hygiene and preventing the spread of pathogens. This research report delves into the multifaceted landscape of the disinfectant wipes market, elucidating key trends, drivers, and innovations shaping the industry.
๐๐๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐
๐๐จ๐ฉ๐ฒ ๐จ๐ ๐ญ๐ก๐ข๐ฌ ๐ซ๐๐ฌ๐๐๐ซ๐๐ก ๐ซ๐๐ฉ๐จ๐ซ๐ญ @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=70359
Key Players and Market Developments
Key playersโฆ
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Stud โฆ
The global ๐ญ๐ข๐ฌ๐ฌ๐ฎ๐ ๐๐๐ง๐ค๐ข๐ง๐ ๐ฆ๐๐ซ๐ค๐๐ญ reached a value of US$ 1,056.4 million in 2017 and is projected to nearly triple to US$ 2,903.3 million by 2026, with a robust Compound Annual Growth Rate (CAGR) of approximately 12.0% from 2018 to 2026. Factors such as increasing awareness about tissue donation, technological advancements, and a growing target patient population are anticipated to propel market growth during this period.
Moreover, the market is expectedโฆ
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
This report by Transparency Market Research, Inc. assesses the present state and future growth potential of the global ๐ฏ๐๐ฌ๐๐ฎ๐ฅ๐๐ซ ๐๐ฅ๐จ๐ฌ๐ฎ๐ซ๐ ๐๐๐ฏ๐ข๐๐๐ฌ ๐ฆ๐๐ซ๐ค๐๐ญ. It features a comprehensive executive summary, offering insights into various segments of the market. Additionally, the report provides detailed analysis and data on product, access type, application, end user, and regional segments within the global market.
Vascular closure devices is estimated to reach a value of ~US$ 1 Bnโฆ
More Releases for RNA
Global RNA Analysis/Transcriptomics Market Report
The Global RNA Analysis / Transcriptomics Market is projected to expand at a CAGR of 12.5% during the forecast period, to hit USD 8.1 Billion by 2026, according to a recent market report compiled by Global Market Estimates. Due to the rising need for personalized medicines, the demand for RNA Analysis / Transcriptomics is expected to raise the market demand.
Browse 156 Market Data Tables and 112 Figures spread through 175โฆ
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te โฆ
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and mayโฆ
Senior experts from Exicure, Roche, GSK, BioNTech RNA Pharmaceuticals & MiNA The โฆ
With less than 4 weeks until SMiโs 10th annual RNA Therapeutics event (http://www.therapeutics-rna.com/openpr) opens its doors in London, UK next month, registration will soon be closing and delegate places are becoming increasingly limited.
Over the course of 2 focused days, attendees will be able to have an exclusive look into key developments in oligonucleotide therapeutics, mRNA technology, delivery mechanisms, and much more, led by industry leaders, scientific pioneers, and academics exploringโฆ
RNA Therapy Improves Vision in Child Blindness, hear more about recent developme โฆ
SMi Reports: In light of recent developments in the field of RNA Therapy, SMiโs 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year.
Leber congenital amaurosis (LCA), one of the most common causes of blindness in children, has been the subject of successful RNA therapy as researchers at the University of Pennsylvania recently published new data showing the success of the new therapy which improvedโฆ
New Confirmed Delegates & Speakers for RNA Therapeutics
SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals onto the speaker panel RNA Therapeutics 2018!
Dr. James Hamilton is currently responsible for all aspects of clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520 and ARC-AAT global programs through Phase 2 of development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He ledโฆ
Introducing the 9th Annual RNA Therapeutics 2018
As the requirement for targeted solutions for chronic diseases continues to grow, the interest of pharmaceutical and biotech companies has increasingly focused towards RNA therapeutics, such that by 2020, the RNA Therapeutics Market is predicted to attain $1.2 billion.
One of the main challenges in RNA Therapeutics continues to be bridging the gap between in-vivo and in-vitro models, hear key case studies on the development on the latest delivery systems andโฆ
